The makers of the CRISPR-based testing platform, called miSHERLOCK, say it could enable people at home or physicians in resource-limited environments to detect SARS-CoV-2—and eventually, other pathogens.
Mariella Bodemeier Loayza Careaga, PhD | Dec 4, 2023 | 6 min read
Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.
Researchers can print cells and biomaterials that make up human tissues, but there’s still a long way to go before fully functional organs can be made to order.
Natalie Knox and the Public Health Agency of Canada’s National Microbiology Laboratory are helping establish a national qPCR-driven wastewater surveillance network for SARS-CoV-2 and other diseases.